Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT04953689

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Conscientiousness Coach

What it measured

Main measures

  • Self -Reflection and Insight Scale (SRIS): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

  • Buffalo Vocational Monitoring Survey (BVMS): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24

  • The Valued Living Questionnaire (VLQ): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24

Other measures (8)

  • NEO Five Factor Inventory (NEOFFI): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

  • Quality of Life in Neurological Disorders (NeuroQol): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

    Quality of life (reported by participants)
  • Beck Depression Inventory 2nd Edition (BDI-II): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

    Mood and sleep
  • Beck Anxiety Inventory (BAI): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

    Mood and sleep
  • Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23): change from baseline to 12 weeks and from baseline to 24 weeks

    At baseline, Week 12, and Week 24.

  • The Symbol Digit Modalities Test (SDMT)

    At baseline only

    Thinking and memory
  • The California Verbal Learning Test Second Edition (CVLT2)

    At baseline only

    Thinking and memory
  • The Brief Visuospatial Memory Test Revised (BVMTR)

    At baseline only

    Thinking and memory

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Has a diagnosis of Multiple Sclerosis or is over 60 years of age. * If an MS patient: is above 18 years of age. * No history of substance dependence/abuse, psychiatric disorders, or any neurological disease other than MS * If an MS patient: has a NEO-FFI Conscientiousness score that is one standard deviation or more below the healthy adult mean (t=40)

Exclusion criteria

• Does not meet one or more of the above inclusion criteria

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This is a validation study of a conscientiousness-based phone app intervention strategy to help people with their health management and employment.

Papers

Loading reviews and guidelines…

History

    1. Started

      Oct 2021

    2. Main results due

      Jun 2024

    3. Finished

      Oct 2024

    Assembled by software from public sources.